Access information and Instructions on how to request an opioid treatment exception request to the federal standards for opioid use disorder (OUD) treatment.
Find information and guidance on how to notify SAMHSA about changes in your program and what changes require notification.
SAMHSA’s OTP Compliance Officers offer ongoing guidance and support as well as process new and renewal certifications for Opioid Treatment Programs (OTPs).
Find contact information for State Opioid Treatment Authorities.
SAMHSA offers tools, training, and technical assistance to practitioners in the fields of mental health and substance use disorders. Find information on SAMHSA training and resources. SAMHSA has developed a Buprenorphine Quick Start Guide (PDF | 1.4 KB) and pocket guide (PDF | 200 KB) for all practitioners seeking to prescribe buprenorphine.
Learn about the federal statutes, regulations, and guidelines that apply to medications for opioid use disorders (MOUD) for practitioners and opioid treatment programs (OTPs). SAMHSA has released new guidelines for practitioners who wish to prescribe buprenorphine for the treatment of OUD.
Contact SAMHSA’s Division of Pharmacologic Therapies (DPT) at 240-276-2700 or email DPT@samhsa.hhs.gov.